Cyclica's Scientific Differentiation Success
In this video, hear from Mike Palovich, PhD, Cyclica’s Chief Science Officer and Head of Drug Discovery, and Julie Owen, Team Lead Drug Discovery. They highlight Cyclica's competitive advantage and validated technology as applied to identifying (and 'repurposing') new drug targets for new indications.
Learn more about our science and platform here: https://cyclicarx.com/science/.
Read the press release on our collaboration with the Structural Genomics Consortium (SGC) here: https://cyclicarx.com/press-releases/...